Insight
Study
May 2022

M&A strategies for specialty-chemical corporates

How can specialty-chemical corporates increase their total shareholder return? Our study provides insight into the industry’s recipe for successful M&A activities. The key takeaways: a) Go small. Corporates with low deal volume focus achieved significantly higher average annual TSR (14,3%) compared to corporates with high deal volume focus (TSR: 5,9%). b) Leverage private equity’s sustained interest in chemical M&A. 

Strategy and Growth
Portfolio Strategy and Buy & Build
Industrials and Automotive
Healthcare and Life Sciences
Reading Time 8 Minutes
M&A strategies for specialty-chemical corporates

ContactGet in touch

Dr. Gerrit Schütte
Dr. Gerrit Schütte
Managing Director
Due Diligence, Value Creation and Exit Readiness, Portfolio Strategy and Buy & Build, Principal Investors and Private Equity, Industrials and Automotive